VB-201 160mg

( DrugBank: VB-201 / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01839214 (ClinicalTrials.gov)	January 2013	21/4/2013	A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis	A Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase ...	Ulcerative Colitis	Drug: VB-201 160mg;Drug: Placebo	Vascular Biogenics Ltd. operating as VBL Therapeutics	NULL	Completed	18 Years	N/A	Both	112	Phase 2	Bulgaria;Hungary;Poland

First Previous1Next Last